Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0V7GC
|
|||
Former ID |
DIB008730
|
|||
Drug Name |
Rolafagrel
|
|||
Synonyms |
FCE-22178
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Nephritis [ICD-11: GB40] | Discontinued in Phase 2 | [1] | |
Company |
Pharmacia & Upjohn AB
|
|||
Structure |
Download2D MOL |
|||
Formula |
C14H12N2O2
|
|||
Canonical SMILES |
C1CC(=CC2=C1C=CC(=C2)C(=O)O)N3C=CN=C3
|
|||
InChI |
1S/C14H12N2O2/c17-14(18)11-2-1-10-3-4-13(8-12(10)7-11)16-6-5-15-9-16/h1-2,5-9H,3-4H2,(H,17,18)
|
|||
InChIKey |
DQEDSIVMYUUZCK-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 89781-55-5
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Thromboxane-A synthase (TBXAS1) | Target Info | Inhibitor | [2] |
BioCyc | C20 prostanoid biosynthesis | |||
KEGG Pathway | Arachidonic acid metabolism | |||
Metabolic pathways | ||||
Platelet activation | ||||
Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
WikiPathways | Prostaglandin Synthesis and Regulation | |||
Arachidonic acid metabolism | ||||
Phase 1 - Functionalization of compounds | ||||
Eicosanoid Synthesis |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001438) | |||
REF 2 | Inhibition by FCE 22178 of platelet and glomerular thromboxane synthase in animal and human kidney disease. Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:707-10. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.